Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Longitudinal collection of local vancomycin resistant enterococci

ABSTRACT: Longitudinal collection of local vancomycin resistant enterococci

PROVIDER: PRJEB49226 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Cajanin Stilbene Acid Inhibited Vancomycin-Resistant Enterococci By Inhibiting Phosphotransferase System

Project description:In order to determine the mechanism of Cajanin Stilbene Acid inhibiting vancomycin-resistant enterococci, we compared the changes in protein expression of enterococci V583 strain before and after treated by Cajanin Stilbene Acid.

2020-05-27 | PXD017522 | Pride

Enterococci sequencing (Addenbrooke's collection)

Project description:Enterococci sequencing (Addenbrooke's collection)

| PRJEB4345 | ENA

Vancomycin resistant Enterococci among COVID-19 patients

Project description:Vancomycin resistant Enterococci among COVID-19 patients

| PRJEB40144 | ENA

Enterococci

Project description:Plasmid derived mobilome sequencing of vancomycin resistant enterococci from river Ganga water

| PRJNA521376 | ENA

Whole genome sequencing of donor-derived vancomycin-resistant enterococci

Project description:Donor-derived vancomycin-resistant enterococci transmission and bloodstream infection after intestinal transplantation

| PRJEB40484 | ENA

Molecular typing of vancomycin-resistant enterococci

Project description:Molecular typing of vancomycin-resistant enterococci: Evaluation of a core genome MLST scheme using pulsed-field gel electrophoresis as the reference method

| PRJEB25424 | ENA

Genomic comparison of vancomycin susceptible and vancomycin intermediate Staphylococcus aureus pairs

Project description:To determine if significant genomic changes are associated with the development of vancomycin intermediate Staphylococcus aureus, genomic DNA microarrays were performed to compare the initial vancomycin susceptible Staphylococcus aureus (VSSA) and a related vancomycin intermediate Staphylococcus aureus (VISA) isolate from five unique patients (five isolate pairs). Keywords: comparative genomic hybridization

2006-11-03 | GSE5047 | GEO

Clostridioides difficile and Vancomycin-resistant Enterococci on shoes of healthcare workers.

Project description:Toxigenic Clostridioides difficile and Vancomycin-resistant Enterococci – new mode of transmission by shoes of healthcare workers? A prospective cohort study.

| PRJEB43517 | ENA

Vancomycin nephrotoxicity assessed by DNA microarray

Project description:The glycopeptide antibiotic vancomycin (VCM) represents one of the last lines of defense against methicillin-resistant Staphylococcus aureus infections. However, vancomycin is nephrotoxic, but the mechanism of toxicity is still unclear. The goal of this study was twofold: (1) gain insights into the molecular mechanisms of vancomycin nephrotoxicity at the genomic level and (2) evaluate potential biomarkers (gene expression profiles) of vancomycin-induced kidney injury Keywords: Dose response

2008-10-23 | GSE7793 | GEO

Cervimycin resistant Staphylococcus aureus strains display a vancomycin intermediate resistant phenotype

Project description:Resistance to antibiotics is an emerging problem and necessitates novel antibacterial therapies. Cervimycins A‒D are natural products of Streptomyces tendae HKI 0179 with promising activity against multidrug resistant staphylococci and vancomycin resistant enterococci. We studied the mode of action of cervimycin C and D by selection of cervimycin resistant (CmR) Staphylococcus aureus strains. Genome sequencing of CmR mutants revealed amino acid exchanges in the essential histidine kinase WalK, the Clp protease proteolytic subunit ClpP or the Clp ATPase ClpC, and the heat shock protein DnaK. Interestingly, all characterized cervimycin resistant mutants harbored a combination of mutations in walK and clpP or clpC. Mutations in the Clp system abolished ClpP or ClpC activity, and the deletion of clpP rendered S. aureus but not B. subtilis cervimycin resistant. The essential gene walK was the second mutational hotspot in the cervimycin resistant S. aureus mutants, which decreased WalK activity in vitro and generated a vancomycin intermediately resistant phenotype, with a thickened cell wall, a slower growth rate, and reduced cell lysis. Transcriptomic and proteomic analysis revealed massive alterations in the CmR strains , with major alterations in the heat shock regulon, the metal ion homeostasis and the carbohydrate metabolism. Taken together, compensatory mutations in cervimycin resistant mutants induced a VISA phenotype in S. aureus, suggesting cell wall metabolism or the ClpCP proteolytic system as primary target of the polyketide antibiotic

2022-09-08 | GSE206309 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data